NCT06516796Completed
Omitting of Lymphadenectomy is Acceptable for Lung Cancer Smaller Than 6 mm in Solid Size
Source: ClinicalTrials.gov · Last updated 24 Jul 2024
Brief summary (registry, in English)
Many studies suggested that selective lymph node sampling was acceptable for specific non-small cell lung cancer (NSCLC). This study aimed to evaluate the acceptability of omitting of lymphadenectomy for selected NSCLC. Patients with small-sized (≤2 cm) NSCLC who underwent surgical resection between 2009 and 2022 were retrospectively screened.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2713 (actual)
- First submitted
- 17 Jul 2024
- Start date
- 1 Jan 2023
- Primary completion date
- 1 Jan 2024
- Lead sponsor
- Liang Chen
- Diseases
- Lung cancer, Childhood cancers
- NCT number
- NCT06516796
What you commit to
- Study type: Observational
- Participants enrolled: 2713
- From 1 Jan 2023 to the primary completion date, 1 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- undergoing preoperative neoadjuvant therapies;
- with compromised resection;
Other illness
- with small cell lung cancer components;
- malignant tumor history over the past five years.
Other
- non-primary NSCLC;
Who the study is looking for
- pathologically confirmed non-small cell lung cancer (NSCLC)
- the maximum tumor diameter ≤2 cm
- receiving surgical treatment between 2009-2022
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University Coordinator of this site? Confirm its status | Nanjing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.